Sr. Director – Technical Services & Manufacturing Sciences (TSMS) – Tech Transfer at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Skills

Key technologies and capabilities for this role

Tech TransferDrug Substance ProcessesDry Oral ProductsManufacturing SciencesProcess CommercializationTechnical LeadershipBusiness Process DevelopmentPlaybooksGlobal ManufacturingDual Sourcing

Questions & Answers

Common questions about this position

What is the employment type for this position?

This is a full-time position.

Is this role remote or does it require working at a specific location?

This information is not specified in the job description.

What are the key responsibilities for the Sr. Director of TSMS – Tech Transfer?

The role involves leading global technical teams in tech transfer of drug substance and dry oral products, developing standardized business processes and Playbooks, ensuring alignment with Lilly’s Single Process Map, and providing strategic portfolio management and organizational leadership.

What is the company culture like at Eli Lilly and Company?

Eli Lilly unites caring with discovery to make life better for people around the world, putting people first, giving best effort to work, and engaging in philanthropy and volunteerism while discovering, developing, and delivering life-changing medicines.

What makes a strong candidate for this Sr. Director role?

Strong candidates will have strategic leadership experience in tech transfer, ability to lead global technical teams, expertise in developing standardized processes and Playbooks, and skills in organizational leadership including talent development and cross-functional collaboration.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free